Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if SVRA is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
49 top institutions tracked
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoverySentiment: unknown
No recent insider trades detected.
Red flags: 1
180 filers reported a long position in SVRA for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| NEA Management Company, LLC | $150.7M | 24.5M | Unchanged |
| Bain Capital Life Sciences Investors, LLC | $108.4M | 17.6M | Unchanged |
| Venrock Adviser, LLC | $90.8M | 14.7M | +7.3% |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $83.6M | 13.6M | Unchanged |
| BlackRock, Inc. | $77M | 12.5M | +10.7% |
| TCG Crossover Management, LLC | $76.2M | 12.4M | Unchanged |
| Frazier Life Sciences Management, L.P. | $59.9M | 9.7M | Unchanged |
| Polar Capital Holdings Plc | $58.8M | 9.5M | Unchanged |
| VANGUARD CAPITAL MANAGEMENT LLC | $48.9M | 7.9M | +1.9% |
| Nantahala Capital Management, LLC | $43M | 7M | -5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.